FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183446991> ?p ?o ?g. }

• W2183446991 endingPage "6" @default.
• W2183446991 startingPage "452" @default.
• W2183446991 abstract "To investigate the frequency and distribution of DRB1 and DQB1 alleles in Patients with rheumatoid arthritis (RA) and analyze the relationship between clinical response to methotrexate (MTX) and the HLA-DR and HLA-DQ genotypes in these patients.In this case-control study, the HLA-DRB1 and HLA-DQB1 polymorphism in 91 RA patients and 91 healthy controls was done using polymerase chain reaction and sequence specific primers.There was no statistical difference in frequencies of HLA-DRB1*03, DRB1*04, DRB1*07, DRB1*10, DRB1*11, DRB1*12, DRB1*13, DRB1*14, DRB1*15 and DRB1*16 genotypes between patients and controls. However, DRB1*01 was found to be significantly more common (p=0.015) in RA patients compared to controls. HLA-DRB1*15 was more common in patients (43.5%) compared to controls (30.8%) but results were not significant. HLA-DRB1*08 and DRB1*09 were present in negligible number in patients as well as controls while HLA-DRB1*12 was conspicuously absent in controls. Similarly, DQB1*06 was also significantly more common (p = 0.01) among the patients compared to healthy control subjects, while there was no statistical difference in the frequencies of DQB1*02, DQB1*03, DQB1*04 and DQB1*05 among the cases and the controls. RA susceptibility in most patients appeared to be associated with the HLA-DRB1*01/DQB1 *06 genotype. Regarding association between HLA-DR or HLA-DQ genotype and clinical response to methotrexate (MTX), the data showed that with the exception of HLA-DRB1*03, there appears to be no association between the particular subtypes of HLA-DR and HLA-DQ. HLA-DRB1*03 was significantly-more common among non-responders to MTX alluding to the possibility that another genes responsible for MTX metabolism, might be in linkage disequilibrium with HLA-DRB1*03 in the Pakistani population, thereby making such individuals non-responsive to MTX-therapy.RA susceptibility in most Pakistani patients is associated with the HLA-DRB1*01/DQB1*06 genotype. HLA-DRB1*03 was found to be significantly more common among non-responders to MTX treatment suggesting that Pakistani patients with this genotype are less likely to benefit from MTX." @default.
• W2183446991 created "2016-06-24" @default.
• W2183446991 creator A5016748744 @default.
• W2183446991 creator A5021151467 @default.
• W2183446991 creator A5030839340 @default.
• W2183446991 creator A5043817722 @default.
• W2183446991 creator A5061943349 @default.
• W2183446991 creator A5066218270 @default.
• W2183446991 date "2006-10-01" @default.
• W2183446991 modified "2023-09-27" @default.
• W2183446991 title "Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate--a hospital-based study." @default.
• W2183446991 cites W145414998 @default.
• W2183446991 cites W1976558151 @default.
• W2183446991 cites W2013711275 @default.
• W2183446991 cites W2023102754 @default.
• W2183446991 cites W2054888624 @default.
• W2183446991 cites W2058253357 @default.
• W2183446991 cites W2063273369 @default.
• W2183446991 cites W2075392899 @default.
• W2183446991 cites W2088180658 @default.
• W2183446991 cites W2093599503 @default.
• W2183446991 cites W2097983536 @default.
• W2183446991 cites W2100407919 @default.
• W2183446991 cites W2103870440 @default.
• W2183446991 cites W2118094114 @default.
• W2183446991 cites W2135916283 @default.
• W2183446991 cites W2174570609 @default.
• W2183446991 cites W2264558523 @default.
• W2183446991 cites W2331320446 @default.
• W2183446991 cites W2397261893 @default.
• W2183446991 cites W2409039531 @default.
• W2183446991 cites W2414582805 @default.
• W2183446991 cites W2419125690 @default.
• W2183446991 cites W70445611 @default.
• W2183446991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17144392" @default.
• W2183446991 hasPublicationYear "2006" @default.
• W2183446991 type Work @default.
• W2183446991 sameAs 2183446991 @default.
• W2183446991 citedByCount "10" @default.
• W2183446991 countsByYear W21834469912014 @default.
• W2183446991 countsByYear W21834469912017 @default.
• W2183446991 countsByYear W21834469912019 @default.
• W2183446991 crossrefType "journal-article" @default.
• W2183446991 hasAuthorship W2183446991A5016748744 @default.
• W2183446991 hasAuthorship W2183446991A5021151467 @default.
• W2183446991 hasAuthorship W2183446991A5030839340 @default.
• W2183446991 hasAuthorship W2183446991A5043817722 @default.
• W2183446991 hasAuthorship W2183446991A5061943349 @default.
• W2183446991 hasAuthorship W2183446991A5066218270 @default.
• W2183446991 hasConcept C104317684 @default.
• W2183446991 hasConcept C126322002 @default.
• W2183446991 hasConcept C135763542 @default.
• W2183446991 hasConcept C146304588 @default.
• W2183446991 hasConcept C147483822 @default.
• W2183446991 hasConcept C180754005 @default.
• W2183446991 hasConcept C188280979 @default.
• W2183446991 hasConcept C197754878 @default.
• W2183446991 hasConcept C203014093 @default.
• W2183446991 hasConcept C2775983672 @default.
• W2183446991 hasConcept C2777077863 @default.
• W2183446991 hasConcept C2777575956 @default.
• W2183446991 hasConcept C2779910283 @default.
• W2183446991 hasConcept C2781059491 @default.
• W2183446991 hasConcept C2781142222 @default.
• W2183446991 hasConcept C54355233 @default.
• W2183446991 hasConcept C71924100 @default.
• W2183446991 hasConcept C86803240 @default.
• W2183446991 hasConcept C90924648 @default.
• W2183446991 hasConceptScore W2183446991C104317684 @default.
• W2183446991 hasConceptScore W2183446991C126322002 @default.
• W2183446991 hasConceptScore W2183446991C135763542 @default.
• W2183446991 hasConceptScore W2183446991C146304588 @default.
• W2183446991 hasConceptScore W2183446991C147483822 @default.
• W2183446991 hasConceptScore W2183446991C180754005 @default.
• W2183446991 hasConceptScore W2183446991C188280979 @default.
• W2183446991 hasConceptScore W2183446991C197754878 @default.
• W2183446991 hasConceptScore W2183446991C203014093 @default.
• W2183446991 hasConceptScore W2183446991C2775983672 @default.
• W2183446991 hasConceptScore W2183446991C2777077863 @default.
• W2183446991 hasConceptScore W2183446991C2777575956 @default.
• W2183446991 hasConceptScore W2183446991C2779910283 @default.
• W2183446991 hasConceptScore W2183446991C2781059491 @default.
• W2183446991 hasConceptScore W2183446991C2781142222 @default.
• W2183446991 hasConceptScore W2183446991C54355233 @default.
• W2183446991 hasConceptScore W2183446991C71924100 @default.
• W2183446991 hasConceptScore W2183446991C86803240 @default.
• W2183446991 hasConceptScore W2183446991C90924648 @default.
• W2183446991 hasIssue "10" @default.
• W2183446991 hasLocation W21834469911 @default.
• W2183446991 hasOpenAccess W2183446991 @default.
• W2183446991 hasPrimaryLocation W21834469911 @default.
• W2183446991 hasRelatedWork W1484685933 @default.
• W2183446991 hasRelatedWork W1969316297 @default.
• W2183446991 hasRelatedWork W1990942785 @default.
• W2183446991 hasRelatedWork W2004856792 @default.
• W2183446991 hasRelatedWork W2024242702 @default.
• W2183446991 hasRelatedWork W2037488468 @default.
• W2183446991 hasRelatedWork W2047121700 @default.

• next